129156-15-6

Upstream product

• 130733-18-5 <4S(4α,5α,6β)>-5-(2-<(4S*,6R*)-6-<2-(t-butyldiphenylsilyloxy)ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl)-6-<(1R*,3S*)-3-ethyl-1-hydroxypent-4-enyl>-4-methylcyclohex-2-enone 
• 130710-58-6 -4-benzyl-3-<β-<(1,3-dioxolan-2-yl)methyl>-α-oxobutyl>oxazolidin-2-one 
• 130710-57-5 -4-benzyl-β-ethyl-γ,2-dioxo-oxazolidine-3-butanal 
• 130710-56-4 -4-benzyl-3-(2-ethyl-1-oxopent-4-enyl)oxazolidin-2-one 
• 130710-60-0 (R)-α-<(1,3-dioxolan-2-yl)methyl>butanal 
• 130710-61-1 (R)-2-(2-ethylbut-3-enyl)-1,3-dioxolane 
• 130710-59-7 (R)-β-<(1,3-dioxolan-2-yl)methyl>butan-1-ol 
• 130710-62-2 (R)-3-ethylpent-4-enal 
• 994-30-9 triethylsilyl chloride 

Downstream Products

• 130710-66-6 <1S(1α,3α,7β,8β,8aβ)>-8-(2-<(4S*,6R*)-6-<2-(t-butyldiphenylsilyloxy)ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl)-3-ethyl-1,2,3,7,8,8a-hexahydro-7-methylnaphthalen-1-yl (R*)-2-methylbutyrate 
• 130710-65-5 <1S(1α,3α,7β,8β,8aβ)>-8-(2-<(4S*,6R*)-6-<2-(t-butyldiphenylsilyloxy)ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl)-3-ethyl-1,2,3,7,8,8a-hexahydro-7-methylnaphthalen-1-ol 
• 129156-25-8 (4S*-cis)-4-<2-(t-butyldiphenylsilyloxy)ethyl>-6-<2-<1S(1α,2α,6β,8β,8aβ)-6-ethyl-1,2,6,7,8,8a-hexahydro-2-methyl-8-(triethylsilyloxy)naphthalen-1-yl>ethyl>-2,2-dimethyl-1,3-dioxolane 
• 129156-25-8 (4S,6R)-4-[2-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-6-[2-((1S,2S,6R,8S,8aR)-6-ethyl-2-methyl-8-triethylsilanyloxy-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl)-ethyl]-2,2-dimethyl-[1,3]dioxane 

Relevant academic research and scientific papers

Chemical Synthesis of 3-Ethylcompactin, an Inhibitor of 3-Hydroxy-3-methylglutarylcoenzyme A Reductase

A method is described for stereocontrolled synthesis of (+)-3-ethylcompactin (1c), a compound that inhibits rat liver HMG CoA reductase with a similar potency to mevinolin.The synthetic approach is a general one and involves linking a pent-4-enal (3) with